Recurrent Fallopian Tube Clear Cell Adenocarcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 1 / 2 | Not Yet Recruiting | 1 |
DB00158 | Folic acid | 1 / 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 1 / 2 | Not Yet Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB16160 | Tolinapant | 1 / 2 | Not Yet Recruiting | 1 |
DB04849 | Cediranib | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
DB18854 | Etigilimab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 | Active Not Recruiting | 1 |
DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 / 3 | Active Not Recruiting | 1 |